Should You Continue to Retain OMCL Stock in Your Portfolio Now?

Zacks Sep 11 08:00 ET

CRL Stock May Benefit From New Neuroscience Research Collaboration

Zacks Sep 9 08:35 ET

Express News | AxoGen Inc - FDA to Notify AxoGen on Bla Review Acceptance Within 60 Days

ReutersSep 6 07:00 ET

Express News | AxoGen Inc - FDA Determination of Approvability Expected Between April and September 2025

ReutersSep 6 07:00 ET

Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft

GlobeNewswireSep 6 07:00 ET

Express News | AxoGen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®

ReutersSep 6 07:00 ET